With COVID-19 vaccines currently in distribution, GWHP Corp remains committed to sourcing and supplying in demand wholesale PPE supplies and COVID-19 diagnostic tests. With many states and countries still facing lockdowns, social distancing measures and required use of PPE gear, Global WholeHeath Partners recognizes that demand is still high for COVID-19 diagnostic testing kits and PPE supplies. We are proud to announce that our standing relationships and partnerships with key players in the industry enable us to source and supply large quantities of these in demand products. Visit our medical supply page online today to view current offerings.
To aid in the slowing of the virus to help end the pandemic, we all can do our part to by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.
Even as the Pfizer and Moderna vaccine are making their way to millions of people across the globe, continued use of PPE supplies will help slow the spread of the virus so we can end this pandemic.
Get in touch with our representatives today to place your wholesale order of PPE supplies or COVID-19 diagnostic testing kits. We stand committed to sourcing these in demand products for interested parties in wholesale capacities. Visit our medical supply page to view current offerings and get in touch with us to place your wholesale order, call 877-568-4947.
About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.